NVAX: Novavax, Inc.
Performance
NVAX +46.37%
Watchlist
Select an item
Summary
NVAX at a glance
NVAX returned +46.37% over the past year and -41.43% a year over five years. Its worst drop in that year was -34.58%, smaller than 48% of stocks on Redstone, and its Sharpe ratio of 0.83 beats 68% of stocks on Redstone. It pays no dividends.
Current Drawdown
-15.05%
Rolling Volatility
90.65%
Actions
Metrics
Risk Indicators
Alpha39.89%
Beta2.03x
Sharpe0.83
Sortino1.42
Omega1.16
Calmar1.34
Martin3.42
Profile
About NVAX
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $1.8B
- Listed
- Dec 1995
- Employees
- 749
- Headquarters
- Gaithersburg, MD
- Website
- novavax.com
Comparisons